Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 074956
Company: FRESENIUS KABI USA
Company: FRESENIUS KABI USA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
DIPYRIDAMOLE | DIPYRIDAMOLE | 5MG/ML | INJECTABLE;INJECTION | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/30/1998 | ORIG-1 | Approval |
Letter (PDF)
Review (PDF) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/74956ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/anda/98/74956_Dipridamole.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/05/2002 | SUPPL-3 | Manufacturing (CMC)-Facility |
Label is not available on this site. |
||
02/15/2001 | SUPPL-2 | Manufacturing (CMC)-Expiration Date |
Label is not available on this site. |
||
08/21/2000 | SUPPL-1 | Manufacturing (CMC)-Microbiology-Processing |
Label is not available on this site. |